|Minimum Order Quantity||10 Vial|
|Vial Quantity||20 ml|
|Packaging Type||Glass Bottle|
, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.
Trastuzumab was approved for medical use in the United States in 1998. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
- 1 Vial with 858 mg of tyophilised Powder Containing 440 mg of Trastuzumab
- 1 vial with 20 ml solvent for herclon
- (Trastuzumab) 440 mg.